Lyell Immunopharma
LYEL
LYEL
127 hedge funds and large institutions have $297M invested in Lyell Immunopharma in 2024 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 45 reducing their positions, and 14 closing their positions.
Holders
127
Holders Change
+8
Holders Change %
+6.72%
% of All Funds
1.84%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
23
Increased
36
Reduced
45
Closed
14
Calls
$14K
Puts
$15K
Net Calls
-$1K
Net Calls Change
-$1K
Top Buyers
| 1 |
OM
1
Opaleye Management
Boston,
Massachusetts
|
$7.48M |
| 2 |
2
Millennium Management
New York
|
$4.54M |
| 3 |
3
JPMorgan Chase & Co
New York
|
$1.46M |
| 4 |
4
D.E. Shaw & Co
New York
|
$833K |
| 5 |
5
Renaissance Technologies
New York
|
$944K |
Top Sellers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$1.75M |
| 2 |
2
Bank of America
Charlotte,
North Carolina
|
$489K |
| 3 |
3
Morgan Stanley
New York
|
$1.22M |
| 4 |
HF
4
HRT Financial
New York
|
$0 |
| 5 |
5
BlackRock
New York
|
$31M |
